IN8bio's total assets for Q3 2025 were $16.77M, a decrease of -13.44% from the previous quarter. INAB total liabilities were $3.58M for the fiscal quarter, a -13.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.